Health officials in Hong Kong have addressed concerns regarding the Sinovac influenza vaccine, stating it is rigorously tested and deemed safe for use in pregnant women. The vaccine, previously offered as part of a government subsidy, has been subjected to extensive research and clinical trials. Experts emphasize the vaccine’s long-standing history and suggest individuals may opt for private sector vaccinations in the current flu season. The vaccine’s safety and efficacy are currently being reviewed by relevant regulatory bodies.
Credits: News – South China Morning Post